Advances in dendritic cell-based vaccine of cancerXUESHU ZHANG; GORDON, John R; XIANG, Jim et al.Cancer biotherapy & radiopharmaceuticals. 2002, Vol 17, Num 6, pp 601-619, issn 1084-9785, 19 p.Article

Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in miceHUACHEN WEI; BOWEN, R; XUESHU ZHANG et al.Carcinogenesis (New York. Print). 1998, Vol 19, Num 8, pp 1509-1514, issn 0143-3334Article

Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genisteinYAN WANG; YAPING E; XUESHU ZHANG et al.Carcinogenesis (New York. Print). 1998, Vol 19, Num 4, pp 649-654, issn 0143-3334Article

Effect of aspirin on protein binding and tissue disposition of oligonucleotide phosphorothioate in ratsAGRAWAL, S; XUESHU ZHANG; QIUYIN CAI et al.Journal of drug targeting. 1998, Vol 5, Num 4, pp 303-312, issn 1061-186XArticle

In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in ratsRUIWEN ZHANG; ZHIHONG LU; XUESHU ZHANG et al.Clinical chemistry (Baltimore, Md.). 1995, Vol 41, Num 6, pp 836-843, issn 0009-9147, 1Article

Preclinical pharmacology of the natural product anticancer agent bryostatin 1, and activator of protein kinase CXUESHU ZHANG; RUIWEN ZHANG; HUI ZHAO et al.Cancer research (Baltimore). 1996, Vol 56, Num 4, pp 802-808, issn 0008-5472Article

Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationSUDHIR AGRAWAL; XUESHU ZHANG; IYER, R. P et al.Biochemical pharmacology. 1995, Vol 50, Num 4, pp 571-576, issn 0006-2952Article

In vivo stability, disposition and metabolism of a hybrid oligonucleotide phosphorothioate in ratsRUIWEN ZHANG; ZHIHONG LU; HUI ZHAO et al.Biochemical pharmacology. 1995, Vol 50, Num 4, pp 545-556, issn 0006-2952Article